[1]
“SERUM OSTEOPROTEGERIN FOR EARLY IDENTIFICATION OF CAD IN TYPE 2 DM PATIENTS”, IJeR, vol. 2, no. 3, pp. 20–50, Jun. 2025, Accessed: May 18, 2026. [Online]. Available: https://ijeres.org/index.php/ijer/article/view/10